on 18 Feb 2020
Last Applicant/ Owned by
331 Treble Cove Road
N. Billerica
MA
01862
Serial Number
88248414 filed on 03rd Jan 2019
Registration Number
5987668 registered on 18th Feb 2020
Filing Basis
1. use application currently
Disclaimer
NO DATA
medical services, namely, radiopharmacy nuclear medicine services diagnostic radiopharmaceutical imaging agents, diagnostic ultrasound contrast agents, and therapeutic agents for the treatment of cardiovascular diseases and disorders, neurological diseases and disorders, brain conditions, lung diseases and disorders, and cancer medical devices used for obtaining access to contrast media vials an Read More
medical devices used for obtaining access to contrast media vials and dispensing the contents of contrast media vials; generator of radioactive technetium for clinical use in nuclear medicine; activation apparatus for agitating an ultrasound contrast agent formulation in a vial for use in the preparation of microspheres, including ultrasound contrast imaging agents for medical purposes
31st May 2009
31st May 2009
medical services, namely, radiopharmacy nuclear medicine services
31st Mar 2008
31st Mar 2008
diagnostic radiopharmaceutical imaging agents, diagnostic ultrasound contrast agents, and therapeutic agents for the treatment of cardiovascular diseases and disorders, neurological diseases and disorders, brain conditions, lung diseases and disorders, and cancer
31st Jul 2008
31st Jul 2008
No 88248414
No Service Mark
No N04692010000
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
18th Feb 2020 | REGISTERED-PRINCIPAL REGISTER |
03rd Dec 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
03rd Dec 2019 | PUBLISHED FOR OPPOSITION |
13th Nov 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
28th Oct 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
25th Oct 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
03rd Oct 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
03rd Oct 2019 | ASSIGNED TO LIE |
03rd Oct 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
26th Sep 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |